Skyrizi topical and Symtuza

• Generic Name: risankizumab
• Dosage Forms: n.a.
• Other Brand Names: Skyrizi

Risankizumab-rzaa is an interleukin-23 antagonist indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

• Generic Name: cobicistat / darunavir / emtricitabine / tenofovir alafenamide
• Dosage Forms: tablet, film coated
• Other Brand Names: Symtuza

Symtuza contains a combination of cobicistat, darunavir, emtricitabine, and tenofovir alafenamide. Cobicistat reduces the action of enzymes in your liver that break down certain antiviral medicines. This allows the antiviral medicines to be used more safely and effectively at lower doses.

Darunavir, emtricitabine and tenofovir are antiviral medicines that prevent human immunodeficiency virus (HIV) from multiplying in your body. HIV can cause acquired immunodeficiency syndrome (AIDS).

Symtuza is a used to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS).

Symtuza is not a cure for HIV or AIDS.